Documents
HPLC Column Screening for Favipiravir on Six Different 100 x 4.6 mm Columns
Six different HPLC columns were screened to highlight retention differences for Favipiravir, an antiviral medication approved for use in Japan to treat resistant cases of influenza, which is also being studied as a potential treatment for COVID-19.
HPLC Column Screening for Favipiravir on Six Different 100 x 4.6 mm Columns
Six different HPLC columns were screened to highlight retention differences for Favipiravir, an antiviral medication approved for use in Japan to treat resistant cases of influenza, which is also being studied as a potential treatment for COVID-19.
Document Type:
Technical Notes
Target Industries:
Techniques:
Brands:
Separation Modes:
Reversed Phase
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
CONNECT WITH US
